Trial Details
RECRUITINGBasic Information
| Clinical ID | c572 |
|---|---|
| Identifier | NCT06606808 |
| Trial Title | Fluorescence Imaging of Risankizumab-800CW in Inflammatory Bowel Disease |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Ulcerative Colitis (UC)|Crohn Disease (CD) |
| Interventions | DRUG: Risankizumab-800CW 4.5 mg|DRUG: Risankizumab-800CW 15 mg|DRUG: Risankizumab-800CW 25 mg|DRUG: Risankizumab-800CW optimal dose |
Participant Information
| Sponsor | University Medical Center Groningen |
|---|---|
| City | Groningen |
| Country/Region | Netherlands |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE1|PHASE2 |
Time Information
| Start Date | 2024-11-08 |
|---|---|
| Primary Completion Date | 2025-08-25 |
| Completion Date | 2025-12-25 |